Skip to main content

HiV-Associated Tuberculosis 2022
Enrollment in this course is by invitation only

Enrollment in this course is by invitation only

About This Course

HIV-associated tuberculosis remains the major cause of death among HIV-infected individuals. New knowledge on effective prevention, early diagnosis and treatment of drug-susceptible TB and drug-resistant TB in HIV-infected individuals has been acquired. The most important latest developments and new recommendations being relevant for your daily practice will be discussed. Moreover, it includes an overview of symptoms and signs of pulmonary and extrapulmonary TB and practical guidance for co-management TB and HIV in daily practice . This course replaces the previous courses on HIV-associated tuberculosis.

This 3 weeks course was prepared in cooperation with Dr. Adele Schwartz Benzaken, Senior Global Medical Director and Dr. Fernanda Fonseca, Associate Global Medical Director, and will be awarded with 4.0 AHF CME credit hours.

What you will learn

  • Risk of TB infection and disease, epidemiology
  • Clinical presentation of HIV-related TB
  • Diagnosis of TB
  • Treatment of drug-susceptible TB
  • Treatment of MDR/XDR TB
  • Prevention of TB
  • Praxis of co-management TB/HIV
  • Course Instructors:

    Course Staff Image #1

    Clemens Richter, MD PhD

    Frequently Asked Questions

    What web browser should I use?

    The platform works best with current versions of Chrome, Edge, Firefox, Internet Explorer, or Safari.

    Enrollment in this course is by invitation only